Business Context and Reporting Period
This Form 8-K reports on the results of the 2026 Annual Meeting of Stockholders held by National Health Investors, Inc. on May 27, 2026. The Company is incorporated in Maryland and its common stock trades on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
As of the record date (March 27, 2026), there were 48,459,369 shares of Common Stock outstanding. A quorum was established with 42,386,953 shares (87.46%) present or represented by proxy. The following matters were approved:
- Proposal 1 (Election of Directors): All seven nominees were elected to serve until the 2027 Annual Meeting. Voting results included significant "For" votes for each nominee, with Robert W. Chapin, Jr. receiving 31,755,734 votes and Candice W. Todd receiving 31,732,706 votes.
- Proposal 2 (Say-on-Pay): The non-binding advisory vote on executive compensation was approved with 30,921,601 votes "For" and 1,349,874 votes "Against."
- Proposal 3 (Auditor Ratification): The selection of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified with 41,389,140 votes "For."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of stockholder voting results.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Board of Directors, which extends until the 2027 Annual Meeting.
- Confirm the engagement of BDO USA, P.C. as the independent auditor for the fiscal year ending December 31, 2026.
- Note the high level of stockholder participation, with 87.46% of outstanding shares represented at the meeting.
- Review the "Against" vote counts for director nominees and executive compensation to gauge stockholder sentiment.